|
|
|
Volumn 36, Issue 1, 2013, Pages 14-24
|
|
[nab-Paclitaxel. Clinical value of an innovative taxane-containing formulation].;nab-paclitaxel. Klinischer Stellenwert einer weiterentwickelten Taxan- Formulierung.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
NANOPARTICLE;
PACLITAXEL;
BREAST TUMOR;
CHEMISTRY;
FEMALE;
HUMAN;
MIDDLE AGED;
NEOPLASM;
REVIEW;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
CHEMISTRY, PHARMACEUTICAL;
FEMALE;
HUMANS;
MIDDLE AGED;
NANOPARTICLES;
NEOPLASMS;
PACLITAXEL;
|
|
EID: 84874754410
PISSN: 03429601
EISSN: None
Source Type: None
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
